Common reasons for rejection of drug registration applications in Singapore include insufficient clinical data, inadequate safety and efficacy evidence, poor manufacturing practices, non-compliance with regulatory guidelines, incomplete documentation, labeling inaccuracies, and lack of bioequivalence studies. These factors can lead to concerns about the drug’s quality, safety, and therapeutic effectiveness.